Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19Derek C. Angus, Balasubramanian Venkatesh, Sebastiaan Hullegie et al.|JAMA|2020Cited by 884
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Anthony Gordon, Paul Mouncey et al.|medRxiv|2021Cited by 137
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Anthony Gordon, Lennie Derde et al.|Intensive Care Medicine|2021Cited by 100
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant SurgeDavid T. Huang, Christopher Seymour, Erin K McCreary et al.|JAMA Network Open|2022Cited by 54
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, Kevin E. Kip, J Ryan Bariola et al.|JAMA Network Open|2022Cited by 36